Andere talen PolyPid Ltd.

Aandelen

PYPD

IL0011326795

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,752 ^USD	-1,12%		+8,01%	+25,07%

14/02	Transcript : PolyPid Ltd., Q4 2023 Earnings Call, Feb 14, 2024
14/02	PolyPid Ltd. Rapporteert winstresultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024	24/04
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference	28/02
PolyPid Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	14/02
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial	12/02
PolyPid Ltd. Announces Enrollment of the 100th Patient in the Ongoing Shield II Phase 3 Trial	12/02
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024	31/01
PolyPid Ltd. announced that it has received $35.01012 million in funding from Dafna Capital Management, LLC, Rosalind Advisors, Inc.	22/01
PolyPid Enters Into $16.2 Million Private Placement Deal	05/01
PolyPid Announces Private Placement for $16 Million in Gross Proceeds	04/01
PolyPid Ltd. announced that it expects to receive $16.216011 million in funding from Dafna Capital Management, LLC, Rosalind Advisors, Inc. and other investors	04/01
PolyPid Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results	08/11
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors	07/11
Polypid Announces the Addition of Dr. Nurit Tweezer-Zaks to Its Board of Directors	07/11
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023	01/11
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule	11-10-23
POLYPID : AMENDED AND RESTATED 2012 SHARE OPTION PLAN - Form 6-K	10-10-23
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023	09-10-23
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX and PLEX Technology Platform	05-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PolyPid Ltd.

Aandelen

PYPD

IL0011326795

Andere talen

Filters